{"id":"W2995934717","doi":"10.1016/s1470-2045(19)30788-0","title":"Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":796,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"UCLH Biomedical Research Centre; National Institute for Health and Care Research; Seattle Genetics; GlaxoSmithKline; U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Refractory (planetary science); Population; Multiple myeloma; Discontinuation; Toxicity; Phases of clinical research; Gastroenterology; Oncology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002344539,0.002166352,0.003500912,0.0005138098,0.0003950815,0.001286108,0.001241801,0.002006968,0.00758782],"category_scores_gemma":[0.001476521,0.0009757181,0.002126217,0.000384864,0.001361912,0.001905129,0.00061792,0.003497451,0.001619245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001005589,"about_ca_system_score_gemma":0.001037643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008629506,"about_ca_topic_score_gemma":0.001635019,"domain_scores_codex":[0.9992618,0.0003848498,0.00003020971,0.0001174856,0.00006294978,0.000142748],"domain_scores_gemma":[0.9993443,0.0001886244,0.000120101,0.00007776303,0.00003452067,0.0002346971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9611711,0.01067624,0.0003975401,0.0006136991,0.0008162075,0.00004371824,0.00006628364,0.0004859287,0.004158867,0.0002326188,0.001003256,0.02033465],"study_design_scores_gemma":[0.944246,0.05338847,0.0007216007,0.00001641883,0.0002068123,0.00003918868,0.00001798094,0.0003055216,0.0002520701,0.0001775332,0.0006126759,0.00001583424],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878787,0.00406339,0.0009700633,0.0009456806,0.0005690603,0.002512936,0.001075712,0.0001839083,0.0018005],"genre_scores_gemma":[0.9764891,0.004210787,0.003201398,0.001702612,0.0005311192,0.005516571,0.001689042,0.00006607998,0.006593105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00758782,"threshold_uncertainty_score":0.02538377,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1334839683588592,"score_gpt":0.452415809330682,"score_spread":0.3189318409718228,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}